​

ProKidney (PROK) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

PROK Stock Forecast

ProKidney (PROK) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $4.67, with a high of $6.00 and a low of $3.00. This represents a 53.62% increase from the last price of $3.04.

$1 $2 $3 $4 $5 $6 High: $6 Avg: $4.67 Low: $3 Last Closed Price: $3.04

PROK Stock Rating

ProKidney stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (71.43%), 1 Hold (14.29%), 1 Sell (14.29%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 1 1 5 Strong Sell Sell Hold Buy Strong Buy

PROK Price Target Upside V Benchmarks

TypeNameUpside
StockProKidney53.62%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$3.04$3.04$3.04
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 25-43-18
Sep, 25-43-18
Aug, 25-33-17
Jul, 25-32-16
Jun, 25-33--6
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 04, 2024Jason GerberryBank of America Securities$3.00$2.4025.00%-1.32%
Sep 03, 2024Justin ZelinBTIG$5.00$2.40108.33%64.47%
Jun 10, 2024Kelly ShiJefferies$6.00$3.0298.68%97.37%
May 28, 2024Justin ZelinBTIG$6.00$3.7161.73%97.37%
Dec 21, 2022Jefferies$15.00$7.30105.48%393.42%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 15, 2025UBSBuyBuyhold
Jul 08, 2025CitigroupBuyBuyhold
Jul 08, 2025Bank of America SecuritiesUnderperformUnderperformhold
Sep 10, 2024GuggenheimBuyinitialise
Sep 03, 2024BTIGBuyBuyhold
Jun 10, 2024JefferiesBuyBuyhold
May 29, 2024Bank of America SecuritiesNeutralNeutralhold
May 28, 2024BTIGBuyBuyhold
Dec 21, 2022JefferiesBuyinitialise
Oct 14, 2022CitigroupBuyinitialise

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.57-----
Avg Forecast$-0.61$-0.58$-0.42$-0.66$-0.89$-0.32
High Forecast$-0.56$-0.55$0.40$-0.57$-0.89$-0.32
Low Forecast$-0.64$-0.61$-0.73$-0.75$-0.89$-0.32
Surprise %-6.56%-----

Revenue Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported-$76.00K----
Avg Forecast----$105.00M-
High Forecast----$105.00M-
Low Forecast----$105.00M-
Surprise %------

Net Income Forecast

$-150M $-110M $-70M $-30M $10M $50M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-35.47M$-102.15M----
Avg Forecast$-35.47M$-35.96M$-10.12M$-40.61M$-54.93M$-19.75M
High Forecast$-34.59M$-34.07M$24.92M$-35.04M$-54.93M$-19.75M
Low Forecast$-39.20M$-37.85M$-45.17M$-46.18M$-54.93M$-19.75M
Surprise %-184.05%----

PROK Forecast FAQ

Is ProKidney stock a buy?

ProKidney stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 1 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that ProKidney is a favorable investment for most analysts.

What is ProKidney's price target?

ProKidney's price target, set by 7 Wall Street analysts, averages $4.67 over the next 12 months. The price target range spans from $3 at the low end to $6 at the high end, suggesting a potential 53.62% change from the previous closing price of $3.04.

How does ProKidney stock forecast compare to its benchmarks?

ProKidney's stock forecast shows a 53.62% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for ProKidney over the past three months?

  • October 2025: 0% Strong Buy, 50.00% Buy, 37.50% Hold, 0% Sell, 12.50% Strong Sell.
  • September 2025: 0% Strong Buy, 50.00% Buy, 37.50% Hold, 0% Sell, 12.50% Strong Sell.
  • August 2025: 0% Strong Buy, 42.86% Buy, 42.86% Hold, 0% Sell, 14.29% Strong Sell.

What is ProKidney’s EPS forecast?

ProKidney's average annual EPS forecast for its fiscal year ending in December 2025 is $-0.42, marking a 0% decrease from the reported $0 in 2024. Estimates for the following years are $-0.66 in 2026, $-0.89 in 2027, and $-0.32 in 2028.

What is ProKidney’s revenue forecast?

ProKidney's average annual revenue forecast for its fiscal year ending in December 2025 is $0, reflecting a -100.00% decrease from the reported $76K in 2024. The forecast for 2026 is $0, followed by $105M for 2027, and $0 for 2028.

What is ProKidney’s net income forecast?

ProKidney's net income forecast for the fiscal year ending in December 2025 stands at $-10.123M, representing a -90.09% decrease from the reported $-102M in 2024. Projections indicate $-40.613M in 2026, $-54.926M in 2027, and $-19.749M in 2028.